1. Home
  2. KELYA vs PRLD Comparison

KELYA vs PRLD Comparison

Compare KELYA & PRLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kelly Services Inc.

KELYA

Kelly Services Inc.

HOLD

Current Price

$15.25

Market Cap

340.1M

ML Signal

HOLD

Logo Prelude Therapeutics Incorporated

PRLD

Prelude Therapeutics Incorporated

HOLD

Current Price

$4.92

Market Cap

391.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KELYA
PRLD
Founded
1946
2016
Country
United States
United States
Employees
4900
N/A
Industry
Professional Services
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
340.1M
391.1M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
KELYA
PRLD
Price
$15.25
$4.92
Analyst Decision
Buy
Strong Buy
Analyst Count
1
3
Target Price
$15.00
$5.67
AVG Volume (30 Days)
336.7K
329.7K
Earning Date
05-07-2026
05-13-2026
Dividend Yield
3.07%
N/A
EPS Growth
N/A
23.21
EPS
N/A
N/A
Revenue
N/A
$12,140,000.00
Revenue This Year
N/A
$320.10
Revenue Next Year
$4.60
$100.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
73.43
52 Week Low
$7.98
$0.75
52 Week High
$17.75
$5.69

Technical Indicators

Market Signals
Indicator
KELYA
PRLD
Relative Strength Index (RSI) 64.45 54.95
Support Level $8.48 $3.92
Resistance Level $16.20 $4.69
Average True Range (ATR) 0.66 0.33
MACD -0.12 0.04
Stochastic Oscillator 33.85 65.94

Price Performance

Historical Comparison
KELYA
PRLD

About KELYA Kelly Services Inc.

Kelly Services Inc is a specialty talent solutions company. The company operates through three reportable segments: i) Enterprise Talent Management, which provides temporary staffing, outsourcing, and permanent placement services across industrial, contact center, and clerical roles, ii) Science, Engineering & Technology, which supplies specialized talent across multiple industries, and iii) Education, which delivers staffing, placement, and executive search services to Pre-K-12 school districts and education organizations in the United States. The majority of the company's revenue is derived from the Enterprise Talent Management segment. Geographically, it generates the maximum revenue from the United States, followed by Europe and the Asia-Pacific Region.

About PRLD Prelude Therapeutics Incorporated

Prelude Therapeutics Incorp is a precision oncology company developing medicines in areas of high unmet need for cancer patients. Its pipeline features selective KAT6A degraders and mutant selective JAK2V617F JH2 inhibitors, new approaches to clinically validated targets with transformative potential for patients. The company is also leveraging its expertise in targeted protein degradation to discover and develop next-generation degrader antibody conjugates (DACs) with novel payloads.

Share on Social Networks: